Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2016 Mar 31;6:23870. doi: 10.1038/srep23870

Prevalence and Risk Factors of Carotid Plaque Among Middle-aged and Elderly Adults in Rural Tianjin, China

Changqing Zhan 1,2,3, Min Shi 2,3, Ying Yang 4, Hongbo Pang 1, Shizao Fei 1, Lingling Bai 2,3, Bin Liu 5, Jun Tu 2,3, Yong Huo 4, Xianjia Ning 2,3, Yan Zhang 4,a, Jinghua Wang 2,3,b
PMCID: PMC4814923  PMID: 27029785

Abstract

Carotid plaque (CP) is associated with cardiovascular and cerebrovascular events. However, population-based studies with a large sample are rare in China, particularly those in the low-income population. We aimed to determine the prevalence of CP and the associated risk factors in the rural areas of northern China. Between April 2014 and June 2014, we recruited 3789 residents aged ≥45 years. B-mode ultrasonography was performed to measure the extent of CP. The prevalence of CP was 40.3% overall, 47.1% in men, and 35.4% in women (P < 0.001). The prevalence of CP increased with increasing age (P < 0.001). The participants with CP were more likely to have hypertension, diabetes, high total cholesterol (TC) levels, and high low-density lipoprotein-cholesterol levels and be a current smoker; however, they were less likely to be obese. Multiple logistic regression analysis, adjusted for confounders, indicated that age, male sex, hypertension, diabetes, current smoking, and high LDL-C levels were the independent risk factors for CP. There was a lower risk of CP with alcohol consumption. The findings suggest that managing the conventional risk factors is crucial to reduce the burden of cardiovascular and cerebrovascular diseases in the low-income population in China.


Cardiovascular disease (CVD), including ischemic heart disease and stroke, is a leading cause of death in both developed and developing countries worldwide1, accounting for nearly 42% of all deaths in 2010. Moreover, the 2005–2015 economic burden of CVD in China is estimated to be approximately 550 billion USD2,3.

Atherosclerosis is the major cause of CVD, and carotid atherosclerosis is associated with an increased risk of CVD and vascular death4,5,6. Stenosis of the internal carotid artery (ICA) is a major risk factor for stroke, with a recurrence rate of 32% at 12 weeks after stroke among patients with symptoms of cerebral ischemia and ≥50% carotid stenosis7. Moreover, there is a 2–4% annual risk and 10% 10-year risk of stroke for patients with severe (>70%) carotid stenosis8,9,10,11.

Several cohort studies have indicated that carotid plaque (CP) and carotid intima-media thickening (CIMT) are risk factors for future CVD12,13,14 and cerebrovascular diseases15,16. Furthermore, asymptomatic and preclinical CP is reportedly a better predictor of vascular events than CIMT15,17,18,19,20,21 and can reflect the degree of atherosclerosis22,23. CP is considered a significant marker on imaging for the future risk of CVD12,24 and has a high sensitivity for identifying subclinical vascular disease4.

Although the associations between CP and CVD risk factors, such as age, sex, hypertension, diabetes, hyperlipidaemia, obesity, smoking status, alcohol consumption, and blood pressure (BP), lipid, and glucose levels have been identified in previous studies25,26,27, data on the associations between CP and CVD risk factors in a population-based in China are limited. Moreover, more than half of the Chinese population lives in rural areas, and they tend to have poor medical insurance, low educational levels, and low income; but large population-based studies among low-income residents are rare.

In the present study, we aimed to determine the prevalence of CP among a low-income population in rural Tianjin, China and to assess the relationships between CP prevalence and the traditional CVD risk factors.

Results

Demographic characteristics

Of the 5380 residents aged ≥45 years, 4012 (75%) residents participated in this survey. After excluding 223 residents with a previous history of stroke or myocardial infarction, 3789 participants were included (1560 [41.2%] men and 2229 [58.8%] women).

The age-standardized prevalence of CP was 40.3% overall, 47.1% in men, and 35.4% in women (P < 0.001). The average size of plaque was 22.48 mm (standard error, 0.58 mm), and the median number of lesions was 1 (range 1 to 7). The mean age was 59.92 (9.70) years in the CP group and 61.13 (9.90) years in the non-CP group. The prevalence of CP increased with increasing age (P < 0.001). Significantly fewer years of education and lower BMIs were observed in the CP group than in the non-CP group (P < 0.001 and P = 0.002, respectively). SBP, DBP, and FBG, TC, and LDL-C levels were significantly higher in the CP group than in the non-CP group (all P < 0.05; Table 1).

Table 1. Demographic characteristics of the participants, based on the presence of carotid plaque (CP).

Characteristics CP Non-CP P
Total, n (%) 1574 (41.5) 2215 (58.5)
Men 782 (50.1) 778 (49.9) <0.001
Women 792 (35.5) 1437 (64.5)  
Age, year, mean (SD) 63.38 (9.49) 61.13 (9.90) <0.001
Age group, n (%)     <0.001
45 ~ 54 years 281 (22.7) 955 (77.3)  
55 ~ 64 years 684 (45.2) 830 (54.8)  
65 ~ 74 years 390 (53.9) 334 (46.1)  
≥75 years 219 (69.5) 96 (30.5)  
Education, year, Mean(SD) 4.91 (3.78) 5.69 (3.61) <0.001
SBP, mean(SD), mmHg 151.58 (23.25) 142.76 (20.60) <0.001
DBP, mean(SD), mmHg 87.32 (11.56) 86.45 (11.28) 0.021
BMI, mean(SD), Kg/m2 25.35 (3.70) 25.72 (3.67) 0.002
FBG, mean(SD), mmol/L 6.09 (1.83) 5.81 (1.34) <0.001
TC, mean(SD), mmol/L 4.99 (1.15) 4.78 (1.04) <0.001
TG, mean(SD), mmol/L 1.76 (1.24) 1.76 (1.31) 0.903
HDL-C, mean(SD), mmol/L 1.45 (0.45) 1.46 (0.47) 0.582
LDL-C, mean(SD), mmol/L 3.07 (1.44) 2.43 (1.02) <0.001

SD, standard deviation; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; FBG, fasting blood glucose; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.

Age-standardized prevalence of carotid plaque according to cardiovascular disease risk factors

The participants with CP were more likely to have hypertension, diabetes, high TC levels, and high LDL-C levels and be current smokers, but were less likely to be obese than participants without CP (Table 2). There were no significant differences in alcohol consumption, high TG levels, and low HDL-C levels.

Table 2. The age-standardized prevalence of carotid plaque by cardiovascular disease risk factor*.

Risk factors Yes No P
Hypertension 43.53 (0.98) 33.64 (1.36) <0.001
Diabetes 49.60 (2.17) 38.78 (0.86) <0.001
BMI groups:     0.030
Normal weight 40.97 (1.36)  
Overweight 39.47 (1.22)  
Obesity 40.25 (1.65)  
Smoking status:     <0.001
Never smoking 37.05 (0.91)  
Ever smoking 36.43 (3.66)  
Current smoking 50.58 (1.79)  
Alcohol consumption:     0.112
Never drinking 39.59 (0.86)  
Ever drinking 52.89 (7.13)  
Current drinking 43.34 (3.24)  
High TC 47.12 (2.53) 39.32 (0.85) 0.001
High TG 40.36 (1.72) 39.93 (0.91) 0.447
Low HDL-C 41.61 (2.11) 39.22 (0.87) 0.478
High LDL-C 66.73 (2.74) 37.86 (0.83) 0.001

TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.

*all data was presented as rate (%) with standard error of rate.

Risk factors for carotid plaque

The multivariate logistic regression analysis indicated that age (OR, 1.07; 95% CI, 1.05–1.08), male sex (OR, 1.75; 95% CI, 1.40–2.18), hypertension (OR, 1.43; 95% CI, 1.18–1.73), diabetes (OR, 1.81; 95% CI, 1.34–2.44), current smoking (OR, 1.43; 95% CI, 1.11–1.85), and high LDL-C levels (OR, 3.92; 95% CI, 2.70–5.69) were the independent risk factors for CP (Table 3). Lower amount of alcohol consumption was associated with a lower risk of CP, with an OR (95% CI) of 0.64 (0.41–0.99, P = 0.048) for those with alcohol intake <300 g, and 0.57 (0.35–0.94, P = 0.026) for those with alcohol intake 300–500 g.

Table 3. Logistic regression analysis for the presence of carotid plaque based on the presence of cardiovascular disease risk factors.

Risk factors Reference Adjusted OR (95%CI) p
Age 1.07 (1.05, 1.08) <0.001
Gender:
 Men Women 1.69 (1.35, 2.11) <0.001
 Education 1.01 (0.98, 1.03) 0.623
 Hypertension Non-hypertension 1.41 (1.16, 1.71) <0.001
 Diabetes Non-diabetes 1.47 (1.17, 1.86) 0.001
BMI:
 Overweight Normal weight 0.88 (0.72, 1.07) 0.186
 Obesity Normal weight 0.88 (0.70, 1.12) 0.309
Smoking status:
 Ever smoking Never smoking 0.86 (0.58, 1.29) 0.475
 Current smoking Never smoking 1.45 (1.11, 1.88) 0.006
Alcohol drinking status:
 Ever drinking Never drinking 1.25 (0.59, 2.68) 0.560
 Current drinking (L1) Never drinking 0.64 (0.41, 0.99) 0.048
 Current drinking (L2) Never drinking 0.57 (0.35, 0.94) 0.026
 Current drinking (L3) Never drinking 0.72 (0.42, 1.24) 0.239
 Current drinking (L4) Never drinking 0.80 (0.51, 1.25) 0.324
High TC Normal TC 0.77 (0.55, 1.08) 0.130
High TG Normal TG 1.01 (0.82, 1.25) 0.910
Low HDL-C Normal HDL-C 0.90 (0.70, 1.14) 0.365
High LDL-C Normal LDL-C 3.92 (2.70, 5.69) <0.001

OR, odds ratio; CI, confidence interval;

L1, amount of alcohol consumption per week <300 g; L2, amount of alcohol consumption per week 300–500 g; L3, amount of alcohol consumption per week 501–750 gram; L4, amount of alcohol consumption per week >750 g.

TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.

Discussion

This report describes the prevalence of and relevant risk factors for CP in the low-income population in China based on a large population-based study, resulting in an overall CP prevalence of 40.3% and a significantly higher prevalence in men (47.1%) than in women (35.4%). In addition to the male sex, older age, hypertension, diabetes, current smoking, and high LDL-C levels were risk factors for CP, whereas alcohol consumption was protective.

Of the few reports that have described population-based studies of the prevalence of CP, the Northern Manhattan Cohort Study (NOMAS), which was a population-based cohort study with a unique race/ethnic distribution of community residents aged ≥39 years, reported CP prevalence of 57% overall, 70% in Caucasian participants, 52% in Hispanic participants, and 58% in black participants28. In Beijing, China, the prevalence of CP was 60.3% among urban residents aged 43–81 years, almost 70% in the elderly aged ≥60 years, and 80% in the elderly aged ≥70 years29. The overall prevalence of CP in the present study of a low-income population was lower than in these previous studies, as were the prevalence in the participants aged 65–74 years (53.9%) and ≥75 years (69.5%). The ethnic diversity or socioeconomic status might explain these differences.

The risk factors for CP in the present study were older age, male sex, hypertension, diabetes, current smoking, and high LDL-C levels, while lower dose alcohol consumption was associated with a lower risk of CP; these findings are supported by those of previous studies. Age is considered an important risk factor for atherosclerotic plaque, and a positive relationship between the prevalence of CP and age has been reported previously30. Moreover, the prevalence of CP is higher in men than in women31. While hypertension and diabetes have been significantly associated with CP12,32,33,34, LDL-C might have the strongest relation with CP35. The risk of CP was 3.9 times higher with high LDL-C levels than with the levels in the reference group. Oxidized LDL-C can enter and accumulate within the arterial walls and is involved in the inflammatory process in atherosclerosis36. Therefore, these conventional risk factors might contribute to CP by inducing endothelial dysfunction, hyperinsulinaemia, hemodynamic stress, and multiple metabolic alterations37,38,39.

The risk of CP in the present study was 36% and 43% lower with a lower amount of alcohol consumption. Alcohol inhibited the progression and initiation of atherosclerotic lesions in mice40. The underlying mechanism might involve the inhibitory effects of ethanol on fatty acid oxidation and attenuation of increased lipid synthesis41.

There were several limitations in this study. First, the study population was from a local town in Tianjin, China, there was the limited representation. Second, the design of cross-section study may have led to a selection bias, especially among those healthy elderly. However, those patients with the previous histories of cardiovascular disease and cerebrovascular disease were excluded in this study, all participants were asymptomatic. This may decrease the bias.

Conclusions

This study was the cross-sectional on the prevalence of CP in a low-income population in China. In this study involving a middle-aged and elderly rural population in northern China, the age-standardized prevalence of CP was 40.3%, which is lower than that reported in developed countries and urban populations. This may be associated with the race and life-style, which is needed to researched further. Older age, male sex, hypertension, diabetes, current smoking, and high LDL-C levels were independent risk factors for CP, whereas a lower amount of alcohol consumption was protective. Therefore, managing these conventional risk factors in low-income populations in China could reduce the burden of CVD and cerebrovascular diseases.

Materials and Methods

Participants and study design

This study was performed between April 2014 and January 2015, with the study population from the Tianjin Brain Study42,43,44,45. In brief, the total population included 14251 persons distributed within 18 administrative villages. Approximately 95% of the residents were low-income farmers. The main source of income was grain production in this area, and the per capita disposable income (an individual’s ability to purchase goods or services) was <1600 US in 201446. In 2011, the average length of education was 5.26 years.

All residents aged ≥45 years without a history of cardiovascular and cerebrovascular diseases from the Tianjin Brain Study were eligible for this study, but those with a history of or current symptomatic cardiovascular and cerebrovascular diseases were excluded.

Demographic information, previous medical history, family history of disease, and behavioural factors were collected using a predesigned questionnaire. A physical examination and assessment of fasting glucose and lipid levels were performed at the same time.

All investigative protocols were approved by the ethics committee of Peking University First Hospital; the methods were carried out in accordance with the approved guidelines, and informed consent was obtained from each participants.

Survey for risk factors

The surveys were conducted through face-to-face interviews by trained research staff to collect name; sex; date of birth; educational level; previous history of hypertension, diabetes mellitus, stroke, transient ischemia, and coronary heart disease; family history of hypertension, diabetes mellitus, stroke, and coronary heart disease; cigarette smoking (≥1 cigarette per day for ≥1 year); and alcohol consumption (drinking alcohol ≥1 time per week for 1 year).

Physical examinations

BP, height, and weight were measured. Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m2). Serum fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels were measured and analysed at the central laboratory of Tianjin Medical University General Hospital. A carotid ultrasonography examination and 12-lead echocardiography were also performed.

Ultrasonography measurements

One trained technician blinded to participants’ information performed all the ultrasound exams. The patients were examined in the supine position using B mode ultrasonography (Terason 3000; Burlington, MA, US) with a 5–12 MHz linear array transducer. Extracranial carotid artery trees (common carotid artery, the bifurcation, internal and external carotid artery) on both sides were screened for plaque. Images were obtained and digitally stored according to a standard protocol. Both longitudinal and transvers dynamic images of each plaque were stored.

Survey Procedure

Local village doctors informed all qualified residents door-to-door according to a predefined procedure one day before examination. We performed physical examination (including blood pressure, weight, and height measurement, carotid ultrasonography, and 12-lead echocardiography examination) and blood sample collection at local village clinics between April 15, 2014 and June 30, 2014. All blood samples were sent to the central laboratory at Tianjin Medical University General Hospital for measurement of total cholesterol, triglyceride, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol levels within 12 hours of collection, and to the central laboratory at Tianjin Ji County People’s Hospital for measurement of fasting blood glucose levels within 2 hours of collection. Measurement of carotid plaque and IMT was performed by one practiced technician between July 1, 2014 and January 8, 2015.

Definitions

Hypertension was defined as systolic BP (SBP) ≥140 mm Hg or diastolic BP (DBP) ≥90 mmHg or taking medication for hypertension. Diabetes was defined as FBG ≥7.0 mmol/L or taking medication for diabetes. Obesity was defined as a BMI ≥28.0 kg/m2, and overweight was defined as a BMI of 24.0–27.9 kg/m247.

High FBG was defined as ≥6.1 mmol/L48. High TC was defined as ≥6.22 mmol/L. High TG was defined as ≥2.26 mmol/L. High LDL-C was defined as ≥4.14 mmol/L, and low HDL-C was defined as ≥1.04 mmol/L49.

Plaques are focal structures that encroach into the arterial lumen by at least 0.5 mm or 50% of the surrounding IMT, or demonstrate a thickness of >1.5 mm, as measured from the intima-lumen interface to the media adventitia interface50. Subjects with carotid plaque were definite as present of one ≥lesions, no matter the numbers of carotid plaque.

Statistical analyses

All participants were categorized based on the presence of CP into the CP and non-CP groups. Continuous variables are presented as mean and standard deviation and were compared between the groups using Student’s t-tests. Categorical variables are presented as frequencies and 95% confidence intervals (CIs) and were compared using Chi-square tests. The age-standardized prevalence of CP was calculated dividing the population into 10 age groups with the direct method using the world standard population: <35, 35–39, 40–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, and ≥75 years51. Associations between CP (binomial dependent variable) and CVD risk factors (independent variables) were determined using univariate and multivariate logistic regression analyses, and the results are presented as unadjusted odds ratios (ORs) and 95% CIs or adjusted ORs and 95% CIs, respectively. Of these CRFs, age and education level were assessed as continuous variables, and history of hypertension and diabetes as binomial variables. BMI and smoking and drinking status were evaluated by categorized variables. BMI was categorized as normal weight, overweight, and obesity, with normal weight as reference; smoking status was divided into never smoking, ever smoking, and current smoking, with never smoking as reference; alcohol consumption was divided into never drinking, ever drinking, current drinking level 1 (alcohol consumption per week <300 g), current drinking level 2 (amount of alcohol consumption per week 300–500 g), current drinking level 3 (amount of alcohol consumption per week 501–750 g), and current drinking level 4 (amount of alcohol consumption per week >750 g) according to the quartile of alcohol consumption amount per week, with never drinking as the reference. A P value <0.05 was considered statistically significant. SPSS for Windows (version 13.0; SPSS Inc., Chicago, IL, USA) was used for analyses.

Additional Information

How to cite this article: Zhan, C. et al. Prevalence and Risk Factors of Carotid Plaque Among Middle-aged and Elderly Adults in Rural Tianjin, China. Sci. Rep. 6, 23870; doi: 10.1038/srep23870 (2016).

Acknowledgments

This study was funded by Tianjin Medical University General Hospital and Peking University First Hospital.

Footnotes

Author Contributions J.W., X.N., Y.Z. and Y.H. contributed in study design. J.W., X.N. and Y.Z. contributed in data collection, data interpretation, drafting, and critical review. J.W. and X.N. contributed in data analysis. C.Z., M.S., Y.Y., H.P., S.F., L.B., B.L. and J.T. contributed in data collection, case diagnosis and confirmation.

References

  1. Lloyd-Jones D. et al. Heart disease and stroke statistics–2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 119, 480–486 (2009). [DOI] [PubMed] [Google Scholar]
  2. The Ministry of Health of the People’s Republic of China: China Health Statistics Yearbook 2011 (China Union Medical University Press, 2011). [Google Scholar]
  3. Murray C. J. & Lopez A. D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 349, 1269–1276 (1997). [DOI] [PubMed] [Google Scholar]
  4. Brook R. D. et al. A negative carotid plaque area test is superior to other non-invasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol. 26(3), 656–662 (2006). [DOI] [PubMed] [Google Scholar]
  5. Prabhakaran S. et al. Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke. 37(11), 2696–2701 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Rubin M. R. et al. Carotid artery plaque thickness is associated with increases serum calcium levels: the Northern Manhattan study. Atherosclerosis. 194(2), 426–432 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. de Weerd M. et al. Prediction of asymptomatic carotid artery stenosis in the general population: identification of high-risk groups. Stroke. 45(8), 2366–2371 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hennerici M. et al. Natural history of asymptomatic extracranial arterial disease. Results of a long-term prospective study. Brain. 110 (pt 3), 777–791 (1987). [DOI] [PubMed] [Google Scholar]
  9. Inzitari D. et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 342, 1693–1700 (2000). [DOI] [PubMed] [Google Scholar]
  10. Norris J. W., Zhu C. Z., Bornstein N. M. & Chambers B. R. Vascular risks of asymptomatic carotid stenosis. Stroke. 22, 1485–1490 (1991). [DOI] [PubMed] [Google Scholar]
  11. O’Holleran L. W., Kennelly M. M., McClurken M. & Johnson J. M. Natural history of asymptomatic carotid plaque. Five year follow-up study. Am J Surg. 154, 659–662 (1987). [DOI] [PubMed] [Google Scholar]
  12. Cao J. J. et al. Association of carotid artery intima-media thickness,plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation. 116, 32–38 (2007). [DOI] [PubMed] [Google Scholar]
  13. Lorenz M. W. et al. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 37, 87–92 (2006). [DOI] [PubMed] [Google Scholar]
  14. van der Meer I. M. et al. Predictive value of noninvasive measures of atherosclerosis for incident Myo-cardial infarction: the Rotterdam Study. Circulation. 109, 1089–1094 (2004). [DOI] [PubMed] [Google Scholar]
  15. Kuo F. et al. Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke. 43, 1755–1760 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Spence J. D. & Rundek T. Toward clinical applications of carotid ultrasound: Intima-media thickness, plaque area, and three-dimensional phenotypes in Ultrasound and Carotid Bifurcation Atherosclerosis (eds Nicolaides A. E. et al. ) 431–448 (Springer-Verlag, 2012). [Google Scholar]
  17. Johnsen S. H. et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: A 6-year follow-up study of 6226 persons: The tromso study. Stroke. 38, 2873–2880 (2007). [DOI] [PubMed] [Google Scholar]
  18. Inaba Y., Chen J. A. & Bergmann S. R. Carotid plaque, compared with carotid intima–media thickness, more accurately predicts coronary artery disease events: A meta-analysis. Atherosclerosis. 220, 128–133 (2012). [DOI] [PubMed] [Google Scholar]
  19. Mathiesen E. B. et al. Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: A 10-year follow-up of 6584 men and women: The tromso study. Stroke. 42, 972–978 (2011). [DOI] [PubMed] [Google Scholar]
  20. Spence J. D. et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 33, 2916–2922 (2002). [DOI] [PubMed] [Google Scholar]
  21. Johnsen S. H. & Mathiesen E. B. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep. 11, 21–27 (2009). [DOI] [PubMed] [Google Scholar]
  22. Hulthe J. et al. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke. 28, 1189–1194 (1997). [DOI] [PubMed] [Google Scholar]
  23. Rundek T. et al. Carotid plaque, a subclinical precursor of vascular events: The Northern Manhattan Study. Neurology. 70(14), 1200–1207 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sillesen H. et al. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinicalarterial disease in the High Risk Plaque BioImage study. JACC Cardiovasc Imaging. 5(7), 681–689 (2012). [DOI] [PubMed] [Google Scholar]
  25. Herder M., Johnsen S. H., Arntzen K. A. & Mathiesen E. B. Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study. Stroke. 43(7), 1818–1823 (2012). [DOI] [PubMed] [Google Scholar]
  26. van der Meer I. M. et al. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study. Stroke. 34, 2374–2379 (2003). [DOI] [PubMed] [Google Scholar]
  27. Chambless L. E. et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987–1998. Am J Epidemiol. 155, 38–47 (2002). [DOI] [PubMed] [Google Scholar]
  28. Yang D. et al. Cigarette Smoking and Carotid Plaque Echodensity in the Northern Manhattan Study. Cerebrovasc dis. 40(3–4), 136–143 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wang W. et al. Distribution characteristics and risk factors of carotid atherosclerosis in middle-aged and elderly Chinese. Chin J Cardiol. 38, 553–557 (2010). [PubMed] [Google Scholar]
  30. Spence J. D., Barnett P. A., Bulman D. E. & Hegele R. A. An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis. Atherosclerosis. 144, 429–434 (1999). [DOI] [PubMed] [Google Scholar]
  31. Roman M. J. et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 144(4), 249–256 (2006). [DOI] [PubMed] [Google Scholar]
  32. Spence J. D. & Hegele R. A. Noninvasive phenotypes of atherosclerosis: similar windows but different views. Stroke. 35, 649–653 (2004). [DOI] [PubMed] [Google Scholar]
  33. Delcker A., Diener H. C. & Wilhelm H. Influence of vascular risk factors for atherosclerotic carotid artery plaque progression. Stroke. 26, 2016–2022 (1995). [DOI] [PubMed] [Google Scholar]
  34. Bowden D. W. et al. Genetic epidemiology of subclinical cardiovascular disease in the Diabetes Heart Study. Ann Hum Genet. 72, 598–610 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Roman M. J. et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 349(25), 2399–2406 (2003). [DOI] [PubMed] [Google Scholar]
  36. Furnkranz A. et al. Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Arterioscler Thromb Vasc Biol. 25(3), 633–638 (2005). [DOI] [PubMed] [Google Scholar]
  37. Paneni F., Beckman J. A., Creager M. A. & Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 34(31), 2436–2443 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Csordas A. & Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 10, 219–230 (2013). [DOI] [PubMed] [Google Scholar]
  39. Su T. C. et al. Y.T. Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan. Stroke. 32(10), 2265–2271 (2001). [PubMed] [Google Scholar]
  40. Emeson E. E. et al. Alcohol inhibits the progression as well as the initiation of atherosclerotic lesions in C57B1/6 hyperlipidemic mice. Alcohol Clin Exp Res. 24, 1456–1466 (2000). [PubMed] [Google Scholar]
  41. Salaspuro M. P. et al. Attenuation of the ethanol-induced hepatic redox change after chronic alcohol consumption in baboons: Metabolic consequences in vivo and in vitro. Hepatology. 1, 33–38 (1981). [DOI] [PubMed] [Google Scholar]
  42. Wang J. et al. Trends of hypertension prevalence, awareness, treatment and control in rural areas of northern China during 1991–2011. J Hum Hypertens. 28, 25–31 (2014). [DOI] [PubMed] [Google Scholar]
  43. Wang J. et al. Sex differences in trends of incidence and mortality of first-ever stroke in rural Tianjin, China, from 1992 to 2012. Stroke. 45, 1626–1631 (2014). [DOI] [PubMed] [Google Scholar]
  44. Wang J. et al. Increasing stroke incidence and prevalence of risk factors in a low-income Chinese Population. Neurology. 84, 374–381 (2015). [DOI] [PubMed] [Google Scholar]
  45. Ning X. et al. Secular Trends in Prevalence of Overweight and Obesity among Adults in Rural Tianjin, China from 1991 to 2011: A Population-Based Study. PLOS One. 9(12), e116019 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. National Bureau of Statistics of China: China Statistical Yearbook (China Statistics Press, 2015). [Google Scholar]
  47. Zhou B. F. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases–report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 15(3), 245–252 (2002). [PubMed] [Google Scholar]
  48. Diabetes branch of the Chinese Medical Association. China Guidelines for Type II Diabetes Mellitus (Peking University Medical Press, 2011). [Google Scholar]
  49. The Joint Committee of Chinese adult Dyslipidemia prevention guide. Guidelines on Prevention and Treatment of Dyslipidemia in Chinese Adults. Chin J Cardiol. 35, 390–419 (2007). [PubMed] [Google Scholar]
  50. Touboul P. J. et al. Mannheim carotid intima-media thickness and plaque consensus (2004–2006–2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussel, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 34, 290–296 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ahmad O. B. B.-P. C., Lopez A. D., Murray C. J. L., Lozano R. & Inoue M. Age standardization of rates: A new who world standard. GPE Discussion Paper Series, No. 31. Geneva, EIP/GPE/EBD, WHO (2001).

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES